Affiliation:
1. Shanghai University of Traditional Chinese Medicine, Shanghai 200000, China
2. Department of Anorectal Traditional Chinese Medicine, the First Medical Centre, General Hospital of Chinese PLA, Beijing 100036, China
3. Department of Coloproctology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, NO.725, South Wanping Road, Xuhui District, Shanghai 200032, China
4. The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550000, China
Abstract
Background. To explore the rules of TCM medication in the treatment of constipation in network pharmacology. Methods. Collect and screen the clinical intervention literature on TCM for constipation from China’s national knowledge infrastructure, Wanfang and VIP databases established a database of TCM for constipation, applied R software (3.3.1) to analyze the pattern of prescriptions for TCM for constipation, and summarized the core prescription. The effective active compounds and action targets in the core prescription were screened by Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Traditional Chinese Medicine Integrated Databases (TCMID), constipation-related targets were derived from the DisGeNET and GeneCards databases, Protein-protein interaction network (PPI) was drawn by STRING database, and enrichment analysis was conducted by the Clusterprofiler package in R software (3.3.1). Finally, molecular docking was used to validate the binding ability of candidate compounds to potential targets. Results. Two hundred sixteen target prescriptions were screened through data mining, involving 226 herbs. Association rule analysis results suggested that the “Angelicae sinensis-Radix-dried rehmanniae-Cistanche deserticola-Atractylodes macrocephala-Astragali Radix” was a strong affinity for medicine. Network pharmacology analysis of the core prescription resulted in the screening of 115 candidate compounds, such as quercetin, kaempferol, mangostin, eugenol A, and beta-sitosterol; 131 potential targets, such as PTGS2, PTGS1, and CHRM3; and 160 signaling pathways, such as lipid and atherosclerosis, proteoglycans in cancer, hepatitis B, Kaposi’s sarcoma-associated herpesvirus infection, and PI3K/AKT pathways. Molecular docking showed that PTGS1-formononetin, PTGS2-kaempferol, and CHRM3-kaempferol were all well bound and well matched. Conclusions. This study provides a new method and ideas for clinical applications of integrated Chinese and western medicine in treating constipation.
Funder
National Natural Science Foundation of China
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference32 articles.
1. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management
2. ZhengJ.Effect of anthraquinone derivative C3 on colon cancer cells through ERK1/2-ERCC1 signaling pathway [PhD Thesis]2019Shanxi University
3. Effect of integrated traditional Chinese and western medicine on constipation after anal fissure operation;C. J. Yuan;Clinical Research and Practice,2019
4. Advances in the treatment of functional constipation;J. F. Weng;Chinese Journal of Clinical Research,2016
5. Research progress of Chinese medicine in the treatment of functional constipation;H. Z. Men;Chinese Journal of Coloproctology,2020